학술논문

An ongoing phase 2a study to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease - Preliminary results
Document Type
Journal
Source
NEUROMUSCULAR DISORDERS; OCT 2012, 22 9-10, p852-p852, 1p.
Subject
Language
English
ISSN
09608966